Interval debulking with HIPEC in patient with VP shunt

R Shanoada1, J Stephens2, Z R Al-Wahab2

  • 1Obstetrics and Gynecology, Corewell Health Dearborn, Dearborn, MI, USA.

Summary

Hyperthermic intraperitoneal chemotherapy (HIPEC) is safe for ovarian cancer patients with ventriculoperitoneal (VP) shunts when managed by a multidisciplinary team. This approach involves intraoperative shunt management and antimicrobial prophylaxis, expanding treatment options.